Clinical Trial Update: Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports efficacy and safety findings for adalimumab in adults with moderately to severely active ulcerative colitis; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2011-03-31